磷酸化急性髓细胞白血病1蛋白抗体

Quantity size:

0.1ml

Concentration:

1mg/ml 磷酸化急性髓细胞白血病1蛋白抗体  Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.

Background:

AML1/Runx1 binds DNA as a monomer and through the Runt domain. DNA binding is increased by heterodimerization with CBFB. Isoform AML1L can neither bind DNA nor heterodimerize and interferes with the transactivation activity of AML1/Runx1. CBF binds to the core site, 5'-PYGPYGGT-3', of a number of enhancers and promoters, including murine leukemia virus,磷酸化急性髓细胞白血病1蛋白抗体  polyomavirus enhancer, T cell receptor enhancers, LCK, IL3 and GMCSF promoters. The alpha subunit binds DNA and appears to have a role in the development of normal hematopoiesis. AML1/Runx1 is expressed in a wide variety of tissues and is expressed at the highest levels in thymus, bone marrow and peripheral blood. Defects in AML1/Runx1 are the cause of familial platelet disorder with associated myeloid malignancy, an autosomal dominant disease characterized by qualitative and quantitative platelet defects, and propensity to develop acute myelogenous leukemia.

磷酸化急性髓细胞白血病1蛋白抗体 Also known as:

RUNX1/AML1 (phospho S303); RUNX1 / AML1 (phospho S303); RUNX1(phospho S303); RUNX1(phospho Ser303); p-AML1 (S303); p-AML1 (Ser303); Acute myeloid leukemia 1; Acute myeloid leukemia 1 protein; alpha subunit core binding factor; AML 1; AML1 EVI 1; Aml1 oncogene; AMLCR 1; AMLCR1; CBFA 2; CBFA2; Core binding factor alpha 2 subunit; Core binding factor runt domain alpha subunit 2; EVI 1; EVI1; HGNC; Oncogene AML 1; PEA2 alpha; PEBP2 alpha B; PEBP2A2; PEBP2aB; Polyomavirus enhancer binding protein 2 alpha B 磷酸化急性髓细胞白血病1蛋白抗体 subunit; Run1; Runt related transcription factor 1; RUNX 1; SL3 3 enhancer factor 1 alpha B subunit; SL3/AKV core binding factor alpha B subunit; RUNX1_HUMAN.

Specificity:

●

Rabbit Polyclonal IgG, affinity purified by Protein A.

●

Reacts with: Human, Horse, .

●

Immunogen: KLH conjugated Synthesised phosphopeptide derived from human RUNX1 磷酸化急性髓细胞白血病1蛋白抗体 around the phosphorylation site of Ser303.

●

Predicted Molecular Weight: 49kDa.

Storage:

Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).

Application:

WB=1:100-500  ELISA=1:500-1000  IHC-P=1:100-500  IHC-F=1:100-500  ICC=1:100-500  IF=1:100-500   
Not yet tested in other applications. 
Optimal working dilutions must be determined by the end user.

kl834Hu01凝血因子Ⅺ(F11)多克隆抗体Polyclonal Antibody to Coagulation Factor XI (F11)

kl834Ra01凝血因子Ⅺ(F11)多克隆抗体Polyclonal Antibody to Coagulation Factor XI (F11)

kl835Hu01轴突生长诱向因子4(Ntn4)多克隆抗体Polyclonal Antibody to Netrin 4 (Ntn4)

kl837Bo01白介素2受体α(IL2Rα)多克隆抗体Polyclonal Antibody to Interleukin 2 Receptor Alpha (IL2Ra)

kl837Hu01白介素2受体α(IL2Rα)多克隆抗体Polyclonal Antibody to Interleukin 2 Receptor Alpha (IL2Ra)

kl837Ra01白介素2受体α(IL2Rα)多克隆抗体Polyclonal Antibody to Interleukin 2 Receptor Alpha (IL2Ra)

kl839Hu01纽蛋白(VCL)多克隆抗体Polyclonal Antibody to Vinculin (VCL)

kl839Mu01纽蛋白(VCL)多克隆抗体Polyclonal Antibody to Vinculin (VCL)

kl840Hu01小乳腺表皮粘蛋白(SBEM)多克隆抗体Polyclonal Antibody to Small Breast Epithelial Mucin (SBEM)

kl842Ra01半胱氨酰白三烯受体2(CYSLTR2)多克隆抗体Polyclonal Antibody to Cysteinyl Leukotriene Receptor 2 (CYSLTR2)

kl844Hu01桩蛋白(Pax)多克隆抗体Polyclonal Antibody to Paxillin (Pax)

kl845Hu01CD83分子(CD83)多克隆抗体Polyclonal Antibody to Cluster Of Differentiation 83 (CD83)

kl845Mu01CD83分子(CD83)多克隆抗体Polyclonal Antibody to Cluster Of Differentiation 83 (CD83)

kl848Hu01核因子κB抑制因子α(IκBα)多克隆抗体Polyclonal Antibody to Inhibitory Subunit Of NF Kappa B Alpha (IkBa)

kl850Hu01β-1,4-半乳糖转移酶1(β4GALT1)多克隆抗体Polyclonal Antibody to Beta-1,4-Galactosyltransferase 1 (b4GALT1)

kl852Hu01含Rho关联卷曲螺旋蛋白激酶2(Rock2)多克隆抗体Polyclonal Antibody to Rho Associated Coiled Coil Containing Protein Kinase 2 (Rock2)

kl853Hu01基质金属蛋白酶19(MMP19)多克隆抗体Polyclonal Antibody to Matrix Metalloproteinase 19 (MMP19)

kl853Mu01基质金属蛋白酶19(MMP19)多克隆抗体Polyclonal Antibody to Matrix Metalloproteinase 19 (MMP19)

kl854Hu01钙腔蛋白(CALU)多克隆抗体Polyclonal Antibody to Calumenin (CALU)

kl854Ra01钙腔蛋白(CALU)多克隆抗体Polyclonal Antibody to Calumenin (CALU)